A meta-analysis of approximately 6,000 participants showed that copper levels were decreased in AD brain specimens, while copper and non-bound ceruloplasmin copper (non-Cp Cu) levels were increased in serum/plasma samples (Squitti et al., 2021; Squitti et al., 2023). Here, CP is linked to Alzheimer disease.